Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NEPHROSIS, LIPOID”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04387448
What this trial is testing

TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

Who this might be right for
Kidney DiseasesDiabetic NephropathiesGlomerulosclerosis, Focal Segmental+8 more
Goldfinch Bio, Inc. 96
Not applicableStudy completedNCT07702981
What this trial is testing

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

Who this might be right for
Membranous NephropathyMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
University Hospital, Ioannina 40
Not applicableActive Not RecruitingNCT02194582
What this trial is testing

Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure

Who this might be right for
Focal Segmental GlomerulosclerosisNephrotic SyndromeEnd Stage Renal Disease+2 more
Beth Israel Deaconess Medical Center 2,050
Not applicableStudy completedNCT01609426
What this trial is testing

Factors of Steroid Dependency in Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic Syndrome
Assistance Publique - Hôpitaux de Paris 351
Large-scale testing (Phase 3)Active Not RecruitingNCT06635720
What this trial is testing

REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)

Who this might be right for
Nephrotic Syndrome in ChildrenNephrotic Syndrome, Minimal ChangeNephrotic Syndrome+1 more
The Hospital for Sick Children 50
Not applicableUnknownNCT06443034
What this trial is testing

Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1

Who this might be right for
Nephrotic SyndromeFocal Segmental GlomerulosclerosisAPOL1 Associated Kidney Disease
Assistance Publique - Hôpitaux de Paris 124
Not applicableStudy completedNCT04075656
What this trial is testing

UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort)

Who this might be right for
Idiopathic Nephrotic Syndrome
Emory University 58
Not applicableUnknownNCT03786263
What this trial is testing

CHILDNEPH The Canadian Childhood Nephrotic Syndrome Study

Who this might be right for
Nephrotic Syndrome in ChildrenNephrotic Syndrome, Minimal ChangeNephrotic Syndrome，Idiopathic
University of Calgary 400
Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Large-scale testing (Phase 3)Study completedNCT01084980
What this trial is testing

Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome

Who this might be right for
Minimal Change Disease
Seoul National University Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05914155
What this trial is testing

Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome

Who this might be right for
Glomerulonephritis, MembranousNephrotic Syndrome，Idiopathic
Shoichi Maruyama MD PhD 88
Not applicableStudy completedNCT00577525
What this trial is testing

Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic Syndrome

Who this might be right for
NEPHROSIS, LIPOID
Assistance Publique - Hôpitaux de Paris 401
Not applicableStudy completedNCT04369183
What this trial is testing

Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change Disease
Istanbul University 25
Not applicableLooking for participantsNCT01209000
What this trial is testing

Nephrotic Syndrome Study Network

Who this might be right for
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
University of Michigan 1,200
Post-approval studies (Phase 4)Study completedNCT03210688
What this trial is testing

Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy

Who this might be right for
Minimal Change DiseaseNephrotic Syndrome
University of Aarhus 71
Large-scale testing (Phase 3)Study completedNCT01268033
What this trial is testing

Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood

Who this might be right for
Childhood Idiopathic Nephrotic Syndrome
University Hospital, Limoges 26
Not applicableLooking for participantsNCT04571658
What this trial is testing

NEPTUNE Match Study

Who this might be right for
Nephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more
University of Michigan 375
Not applicableStudy completedNCT04169776
What this trial is testing

Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic SyndromeFrequently Relapsing Nephrotic Syndrome
Northwell Health 7
Not applicableNot Yet RecruitingNCT07685093
What this trial is testing

Comparison of Efficacy and Safety of Albumin Versus Fresh Frozen Plasma in Managing Diuretic Resistant Edema in Children With Idiopathic Nephrotic Syndrome.

Who this might be right for
Idiopathic Nephrotic Syndrome (INS)
Qamar Shafiq 56
Large-scale testing (Phase 3)Not Yet RecruitingNCT06405100
What this trial is testing

Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD

Who this might be right for
Minimal Change Disease
Air Force Military Medical University, China 81
Next Page